{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Fairfield",
      "state": "NJ",
      "country": "United States",
      "classification": "Class III",
      "openfda": {
        "application_number": [
          "M015"
        ],
        "brand_name": [
          "DIBUCAINE"
        ],
        "generic_name": [
          "DIBUCAINE"
        ],
        "manufacturer_name": [
          "Akron Pharma Inc."
        ],
        "product_ndc": [
          "71399-2829"
        ],
        "product_type": [
          "HUMAN OTC DRUG"
        ],
        "route": [
          "TOPICAL"
        ],
        "substance_name": [
          "DIBUCAINE"
        ],
        "rxcui": [
          "238784"
        ],
        "spl_id": [
          "da90939a-75f0-4b82-94ff-8611fe746715"
        ],
        "spl_set_id": [
          "60469e43-ab6f-46d3-a1df-00e58275f565"
        ],
        "package_ndc": [
          "71399-2829-1",
          "71399-2829-2"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000185508",
          "N0000175629",
          "N0000184306",
          "M0000728"
        ],
        "pharm_class_epc": [
          "Standardized Chemical Allergen [EPC]"
        ],
        "pharm_class_pe": [
          "Increased Histamine Release [PE]",
          "Cell-mediated Immunity [PE]"
        ],
        "pharm_class_cs": [
          "Allergens [CS]"
        ],
        "unii": [
          "L6JW2TJG99"
        ]
      },
      "product_type": "Drugs",
      "event_id": "91785",
      "recalling_firm": "Akron Pharma, Inc.",
      "address_1": "373 Us Highway 46 Ste 117",
      "address_2": "",
      "postal_code": "07004-2456",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide within the United States",
      "recall_number": "D-0454-2023",
      "product_description": "DIBUCAINE 1% HEMORRHOIDAL OINTMENT, 1 oz. (28 gm), Manufactured for: Akron Pharma Inc. Fairfield NJ 07004, NDC 71399-2829-1",
      "product_quantity": "4,416 tubes",
      "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date",
      "recall_initiation_date": "20230217",
      "center_classification_date": "20230309",
      "termination_date": "20240909",
      "report_date": "20230315",
      "code_info": "Lot #: 2206016, Exp. date 05/2024",
      "more_code_info": ""
    }
  ]
}